Log in to save to my catalogue

Cerebrospinal fluid amyloid-[beta] and cerebral microbleed are associated with distinct neuropsychia...

Cerebrospinal fluid amyloid-[beta] and cerebral microbleed are associated with distinct neuropsychia...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A788691908

Cerebrospinal fluid amyloid-[beta] and cerebral microbleed are associated with distinct neuropsychiatric sub-syndromes in cognitively impaired patients

About this item

Full title

Cerebrospinal fluid amyloid-[beta] and cerebral microbleed are associated with distinct neuropsychiatric sub-syndromes in cognitively impaired patients

Publisher

BioMed Central Ltd

Journal title

Alzheimer's research & therapy, 2024-04, Vol.16 (1)

Language

English

Formats

Publication information

Publisher

BioMed Central Ltd

More information

Scope and Contents

Contents

Background Neuropsychiatric symptoms (NPS) are prevalent in cognitively impaired individuals including Alzheimer's disease (AD) dementia and mild cognitive impairment (MCI). Whereas several studies have reported the associations between NPS with AD pathologic biomarkers and cerebral small vessel disease (SVD), but it remains unknown whether AD path...

Alternative Titles

Full title

Cerebrospinal fluid amyloid-[beta] and cerebral microbleed are associated with distinct neuropsychiatric sub-syndromes in cognitively impaired patients

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_gale_infotracmisc_A788691908

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A788691908

Other Identifiers

ISSN

1758-9193

E-ISSN

1758-9193

DOI

10.1186/s13195-024-01434-7

How to access this item